Biofrontera AG (FRA:B8FK)
Germany · Delayed Price · Currency is EUR 2.700
+0.040 (1.50%)
At close: Jul 30, 2025, 10:00 PM CET
Biofrontera AG Company Description
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
The company offers Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma.
It also provides RhodoLED XL lamp for the treatment of multiple interspersed lesions; and Belixos, a cosmetic product for irritated and sensitive skin.
The company has a license and supply agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
Biofrontera AG
| Country | Germany |
| Founded | 1997 |
| Industry | Pharmaceutical Preparations |
| Employees | 88 |
Contact Details
Address: Hemmelrather Weg 201 Leverkusen, 51377 Germany | |
| Phone | 49 214 87632 0 |
| Website | biofrontera.com |
Stock Details
| Ticker Symbol | B8FK |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |